El-Sherif O, Jiang ZG, Curry MP et al. Baseline Factors Associated with Improvements in Decompensated Cirrhosis in Patients with HCV. Gastroenterology. 2018 Jun; 154(8):2111-2121
The BE3A Score is a tool designed to assist clinicians to predict the clinical outcome of direct anti-viral treatment among patients with decompensated HCV cirrhosis (Child-Pugh B or C) in 36 weeks since the beginning of treatment.